COR Cencora, Inc. Insider Trading

Director Lauren M Tyler bought 550 COR shares at $270.23; holdings increased to 4,359 shares (+14.4%)

Lauren M Tyler, a Cencora director, purchased 550 shares at $270.23 for $148,626.50, raising her holdings from 3,809 to 4,359 shares—a 14.4% increase in her position. The purchase occurred when the stock was trading 24.6% below its 52-week high of $377.54, though it has recovered 3.5% over the past 30 days after declining 10.6% over 90 days. Cencora's fundamentals remain solid with $78.4B in revenue, net income of $1.6B, and 9.3% annual revenue growth, trading at a P/E of 21.72 on a $55.3B market cap. The transaction represents a discretionary open-market purchase by a board member during a period of recent price weakness, adding to an existing substantial shareholding.

Cencora director Dermot Durcan buys 4,000 shares at $274.19, adding 14.4% to holdings amid 28.1% pullback from 52-week high

Director Dermot Mark Durcan purchased 4,000 shares of Cencora at $274.19 on 2026-06-18, increasing his position from 27.8K to 31.8K shares. The purchase occurs while COR trades 28.1% below its 52-week high of $377.54 and has declined 17.1% over the past 90 days. Durcan's cross-ticker track record shows 2 prior open-market buys with a 100% 90-day win rate (avg +10.1% return), and his prior COR purchase on 2024-05-24 returned +10.1% at the 90-day mark. However, the stock's recent momentum—down 1.3% in 30 days and 17.1% in 90 days—contrasts with his historical pattern of well-timed accumulation across other securities, warranting attention to whether current fundamentals justify increased exposure or whether this represents purchase into an extended decline.

Director Dermot Mark Durcan bought 4,000 COR shares at $266.26; stock down 29.1% from 52-week high, prior COR buy returned +10.1% in 90 days.

Durcan's $1,065,040 purchase of 4,000 shares (16.8% increase to his 27.8K total holding) occurs as Cencora trades at $267.71, down 29.1% from its 52-week high of $377.54 and off 28.1% over the past 90 days. His prior open-market purchase of Cencora stock on 2024-05-24 generated a 90-day return of +10.1%, demonstrating a prior instance of well-timed buying at this ticker. Against a backdrop of revenue of $78.4B with 9.3% annual growth and a P/E of 20.44, the director is adding to his position during a period of significant price depreciation. The timing relative to the stock's recent downward trajectory and his demonstrated track record of successful buys at this company merits attention to whether this signals conviction in the company's recovery fundamentals.

COR President & CEO Mauch sold 3,762 shares at $358.94 (2/20/26); holds 65,393 shares post-sale

Robert P. Mauch, President & CEO of Cencora, executed a sale of 3,762 shares on 2026-02-20 at $358.94, reducing his holdings by 5.4% to 65,393 shares and realizing $1,350,332.28. The transaction occurred at a price 1.5% below the current market price of $364.38 and near the 52-week high of $374.75, suggesting the sale occurred near elevated valuation levels. His same-ticker sales history at COR shows mixed timing results: one prior sale (2025-09-18) was well-timed with an 18.3% post-sale decline over 90 days, but two other measurable sales declined post-transaction (2025-11-18 at -1.6% over 90 days and 2025-10-20 at +8.6% post-sale), indicating 1 of 3 prior same-ticker sells at COR were well-timed at the 90-day mark. His broader cross-ticker track record shows 16 prior open-market sales with an average 90-day return of +8.2%, suggesting his sells have generally been poorly timed historically, though his cross-ticker well-timed rate of 21.43% indicates modest predictive signal. The sale maintains substantial remaining exposure (65,393 shares), consistent with continued material equity stake in the company.

COR CEO Mauch sold 5,096 shares at $354.73 on 2026-01-20 for $1.8M; stock now at $352.47.

Robert P. Mauch, President & CEO of Cencora, sold 5,096 shares at $354.73, reducing holdings from 71,822 to 66,726 shares. The sale occurred near the 52-week high ($374.75), with the stock currently -6.0% from that peak, suggesting reasonable execution near recent strength. Mauch's same-ticker history at COR shows 5 prior sales over the past five months, with mixed 90-day timing results: 0 of 3 measurable sales were well-timed by the 90-day measure, and the two most recent sales (December and November 2025) have not yet produced measurable 90-day outcomes. His cross-ticker track record shows a 15.38% well-timed rate across 15 prior sells with an average 90-day return of +8.9%, indicating his sells historically have not preceded declines. The transaction value of $1.8M against a market cap of $68.4B represents a modest position adjustment for a company trading at a P/E of 35.21.

EVP Battaglia sells 1,677 COR shares at $345.00; holds 18,796 shares post-transaction as stock down 7.0% in 30 days.

Silvana Battaglia, Executive Vice President, sold 1,677 shares of Cencora for $578,565.00 at $345.00, reducing her holding by 8.2% to 18,796 shares. The transaction occurs as the stock has declined 7.0% over the prior 30 days and trades 9.3% below its 52-week high of $374.75. At the same ticker, her 4 prior sells have shown a mixed pattern: one sale was well-timed (90d return -2.5% in June 2025), while three others saw the stock rise after the sale, indicating poor timing on those occasions. Her cross-ticker track record shows a 25.00% well-timed rate on sells overall, suggesting limited predictive timing ability. The company trades at a P/E of 33.97 with recent quarterly revenue of $80.7B and annual growth of 9.3%, providing some fundamental context but not explaining the near-term price weakness.

EVP Elizabeth S Campbell sold 3,351 shares of COR at $342.10 on 2025-12-19 for $1,146,377.10; stock has declined 9.3% from 52-week high.

Elizabeth S Campbell, Executive Vice President at Cencora, sold 3,351 shares at $342.10 on 2025-12-19, reducing her holdings by 12.3% from 27,242 to 23,891 shares. The stock is currently trading at $340.03, down 7.0% in the 30 days since the transaction and 9.3% below its 52-week high of $374.75. At the same ticker (COR), Campbell's prior four measurable sales showed mixed outcomes: three generated positive 30-day returns ranging from 6.1% to 8.0%, while one sale in March 2025 posted a 90-day gain of 9.5% and another from December 2023 gained 16.9% over 90 days—suggesting sporadic success in timing this specific position. The company itself remains fundamentally solid with $80.7B in annual revenue, 9.3% revenue growth, and a $66.0B market cap, though the elevated P/E of 33.97 reflects current valuation expectations.

Cencora CEO Mauch sells 5,096 shares at $343.45; stock down 7.0% in 30 days, 90d prior sales showed mixed outcomes.

Mauch sold 5,096 shares (5.1K shares) at $343.45 on 2025-12-18, reducing his holdings from 73.2K to 68.1K shares (-7.0% net change). The stock has fallen 7.0% over the prior 30 days and is -9.3% from its 52-week high of $374.75. His cross-ticker track record shows 16.67% well-timed sells (low success rate), but at COR specifically, none of his 3 measurable prior 90-day sales were well-timed—the stock rose an average of +16.7% after those sales, meaning he sold before rallies. COR remains a large-cap growth name with 33.97 P/E and 9.3% annual revenue growth, trading at $340.03 currently (down 9.3% from peak), so the sale occurred into a sector or market headwind rather than a strategic exit from deteriorating fundamentals.

SVP & Chief Accounting Officer Krikorian Lazarus sells 4,031 shares of Cencora at $343.24; $1.4M transaction

Krikorian Lazarus, serving as SVP & Chief Accounting Officer, executed a sale of 4,031 shares at $343.24 on 2025-12-17, reducing his holdings from 21,185 shares to 17,154 shares—a 19.0% reduction in stake. The transaction occurred at a price $2.31 above the current price of $340.93, though the stock remains 9.0% below its 52-week high of $374.75. Cencora's fundamentals show strong performance with revenue of $80,663,532,000.00 and net income of $687,402,000.00, supported by 9.3% annual revenue growth and a market cap of $66,138,184,862.92. The sale appears discretionary and occurs in a context where the stock has declined 5.5% over the past 30 days despite posting 17.6% gains over 90 days, suggesting the insider executed this transaction amid mixed near-term momentum.

Cencora CEO Robert Mauch sold 5,096 shares at $366.64 for $1.9M, reducing holdings 7.2%; stock up 10.2% in 30 days post-sale.

Robert Mauch, President & CEO, sold 5,096 shares at $366.64 on 2025-11-18, reducing his holdings from 70,842 to 65,746 shares. The sale occurred near the 52-week high of $365.45. In his prior trades at Cencora, only 1 of 3 sales with measurable 90-day outcomes were well-timed (negative 90d return), while 2 resulted in subsequent gains (90d returns of +23.3% and +8.6%), indicating the stock often rose after his recent sales. His cross-ticker track record shows a 18.18% well-timed rate across 13 prior sells, suggesting mixed historical accuracy in capturing downside moves. The current price of $360.73 is only 1.3% below the 52-week high, leaving limited room for the stock to advance further, though the +10.2% 30-day gain since his sale represents price strength post-execution.